Trypanosomiasis, African: Clinical Trials

9 trials for Trypanosomiasis, African, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated. 9 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 39Completed 7, Terminated 2
Phase 26Completed 5, Terminated 1

Follow Trypanosomiasis, African: new trials by email Literature Review of Trypanosomiasis, African trials Research Report on Trypanosomiasis, African

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients
Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases352022-07-092026-04-06
Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects
Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases12082021-12-302025-03-20
Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases452019-09-292025-01-30
Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage
Fexinidazole - Trypanosomiasis, African, Sleeping Sickness
Phase 3CompletedDrugs for Neglected Diseases1742016-11-102025-01-08
Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense
Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases2082016-10-112025-09-17
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness
Phase 2 / Phase 3CompletedDrugs for Neglected Diseases3942012-10-012018-02-20
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African
Phase 2 / Phase 3TerminatedEpicentre312002-10-012007-06-21
Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis
melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d, melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d, nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d - Trypanosomiasis, African
Phase 3TerminatedEpicentre4352001-03-012006-05-26
Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
Eflornithine, Nifurtimox - Trypanosomiasis, African
Phase 3CompletedDrugs for Neglected Diseases2802016-09-29

Narrower conditions

Infections (3)  ·  Trypanosomiasis (2)  ·  Neglected Diseases (1)

Broader conditions

Euglenozoa Infections (9)  ·  Parasitic Diseases (9)  ·  Protozoan Infections (9)  ·  Vector Borne Diseases (9)  ·  Trypanosomiasis (7)  ·  Infections (6)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Eflornithine (4)  ·  Nifurtimox (3)  ·  fexinidazole (3)  ·  Melarsoprol (1)  ·  SCYX 7158 (1)

Sponsors

Drugs for Neglected Diseases (7)  ·  Epicentre (2)

Countries

Democratic Republic of the Congo (6)  ·  Guinea (4)  ·  Uganda (3)  ·  Republic of the Congo (2)  ·  Central African Republic (1)  ·  Malawi (1)

Top investigators

Gerardo Priotto, MD, MPH (2)  ·  Digas Ngolo Tete, MPH (1)  ·  Els Torreele, PhD (1)  ·  Enock Matovu, Prof (1)  ·  Gerardo Priotto, MD MPH (1)  ·  Mamadou Camara, PhD (1)  ·  Patrice Piola, MD MSc (1)  ·  Victor Kande Betu Kumeso, Dr (1)  ·  Victor Kande Betu Kumeso, Dr. (1)  ·  Victor Kande Betu Kumeso, MD (1)

Results publications

PMID 19559476, PMID 29113731, PMID 36460027, PMID 40288399, PMID 40288400